Highly efficient, non-invasive therapeutic options trusted by medical professionals and surgical institutions across Rwanda.
Over the past decade, Rwanda has experienced a significant transformation in its healthcare infrastructure, driven by strategic national initiatives such as Vision 2050. From the expansion of teaching hospitals like the Centre Hospitalier Universitaire de Kigali (CHUK) to the growth of private clinics, there is an escalating demand for state-of-the-art dermatological and wound care solutions. As surgeries, post-trauma interventions, and C-section procedures become more accessible, preventing abnormal scaring, specifically hypertrophic scars and keloids, has emerged as a key focus for local clinicians.
In patients with darker skin phototypes (Fitzpatrick Skin Types V and VI), which are predominant in Rwanda, the risk of keloid formation is biologically higher. Studies indicate that minor skin injuries, surgical incisions, or burns can trigger an overproduction of collagen, leading to painful and disfiguring keloid tissue. Medical professionals in Kigali are increasingly shifting away from invasive scar removal therapies, preferring non-invasive, gold-standard interventions like medical-grade silicone scar sheets to regulate the healing microenvironment.
Silicone sheets mimic the natural epidermal barrier, reducing Transepidermal Water Loss (TEWL). This hydration downregulates fibroblast activity, preventing the collagen overgrowth that causes keloids.
Specifically designed to provide stable, long-term adhesion without inducing secondary mechanical irritation, making them exceptionally safe for sensitive and hyperpigmentation-prone skin.
Ensuring high-efficiency skin recovery across diverse medical departments, from maternity wards to burn trauma units.
Maternal healthcare is a national priority in Rwanda. With the increase in hospital-assisted deliveries and Caesarean sections, silicone scar sheets have become the standard recommendation to ensure clean, flat scars, helping new mothers recover both physically and cosmetically.
In collaborative emergency wards in Kigali and regional hospitals, burn victims and trauma survivors suffer from high-tension scars over joints. Flexible, high-adhesion silicone tapes help maintain mobility while softening thick scar tissue.
Private dermatology clinics in Rwanda are introducing advanced aesthetic procedures. Post-acne surgery and benign growth removals benefit significantly from transparent, color-reducing emollient adhesive patches that accelerate healing without drawing attention.
Hubei ProMix Medical Co., Ltd. brings over two decades of technical expertise directly to sub-Saharan Africa's medical supply chains.
Medical procurement officers in Rwanda—whether managing government tenders through the Rwanda Biomedical Centre (RBC) or sourcing for private hospital groups—face chronic logistics challenges. High shipping costs, clearance delays, and fluctuating batch quality can compromise public health outcomes.
At Hubei ProMix Medical Co., Ltd., we resolve these challenges using our advanced Industry 4.0 manufacturing infrastructure. Our production lines integrate automated coating, precise laminating, and robotic die-cutting systems. This high degree of automation ensures absolute consistency in thickness, adhesion strength, and biocompatibility across millions of units.
By bypassing multiple layers of intermediaries, we establish a direct-to-port supply route from Hubei to Kigali via major shipping corridors, offering stable pricing and predictable lead times. Our robust raw material reserves guarantee that even during sudden global demand spikes, we can maintain production schedules and safeguard your inventory.
We control every step of our manufacturing workflow inside ISO-certified cleanrooms, ensuring medical-grade sterility and performance.
Integrating research, development, and global logistics to deliver advanced medical materials where they are needed most.
Hubei ProMix Medical Co., Ltd. is a modern high-tech enterprise integrating research and development, manufacturing, sales, and service of advanced medical materials. Founded in 2002 and located in Huazhong International Industrial Park, ProMix Medical has grown into a diversified industrial group with more than ten wholly owned subsidiaries, covering sectors such as medical technology, medical devices, biopharmaceuticals, and research institutes. Backed by over 20 years of industry experience, the company has established a strong foundation in innovation and product development.
ProMix Medical holds more than 100 intellectual property rights, including invention patents and utility model patents. The company has passed multiple international quality management system certifications such as ISO 13485, ISO 9001, ISO 14001, and ISO 45001. Our advanced wound care products are certified by global regulatory authorities including CE, FDA, TGA, and HSA, and are exported to over 170 countries and regions worldwide. In the domestic market, the company holds nearly 100 NMPA certifications and serves more than 20,000 medical institutions.
ProMix Medical is committed to promoting a modern, innovative, and technology-driven healthcare philosophy rooted in the wisdom of traditional Chinese medicine. By integrating advanced scientific research with traditional healing concepts, the company develops safe, effective, and high-quality healthcare products. With a focus on purity, innovation, and technological excellence, ProMix continuously delivers products that meet evolving global healthcare standards. The brand reflects not only technological advancement but also a deep commitment to improving quality of life, representing a harmonious blend of tradition, innovation, and human-centered care.
When sourcing medical-grade silicone scar sheets for Rwanda or the wider East African Community (EAC), procurement officers must evaluate key mechanical and biocompatibility criteria. Not all silicone sheets are manufactured to the same standard. The quality of raw polydimethylsiloxane (PDMS) directly dictates patient compliance and therapeutic efficacy.
| Evaluation Parameter | ProMix Medical Specifications | Relevance to Rwanda Clinical Use |
|---|---|---|
| Raw Material Purity | 100% Medical-Grade Cross-linked Polydimethylsiloxane | Prevents skin sensitization and irritation on sensitive skin types. |
| Vapor Transmission Rate | Optimized for local humidity levels | Maintains proper occlusion without causing skin maceration in tropical climates. |
| Adhesive Strength | Gentle, pressure-sensitive silicone gel layer | Allows painless peeling and clean removal from newly formed fragile tissue. |
| Durability & Washability | Reusable for up to 14–28 days (washable) | Reduces the cost burden for patients in public hospital settings. |
| Compliance Certificates | FDA registered, CE certified (MDR compliant), ISO 13485 | Simplifies regulatory import approvals through the Rwanda Food and Drugs Authority (FDA). |
Essential information regarding specifications, importing, regulatory compliance, and customized OEM solutions.
A comprehensive catalog of clinical and home-care scar treatment formulations available for wholesale and custom OEM orders.
ProMix Medical
